These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18438776)

  • 1. In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease.
    Rimkunas VM; Graham MJ; Crooke RM; Liscum L
    Hepatology; 2008 May; 47(5):1504-12. PubMed ID: 18438776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an anti-tumor necrosis factor therapeutic in a mouse model of Niemann-Pick C liver disease.
    Vincent M; Sayre NL; Graham MJ; Crooke RM; Shealy DJ; Liscum L
    PLoS One; 2010 Sep; 5(9):e12941. PubMed ID: 20886067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from liver disease in a Niemann-Pick type C mouse model.
    Sayre NL; Rimkunas VM; Graham MJ; Crooke RM; Liscum L
    J Lipid Res; 2010 Aug; 51(8):2372-83. PubMed ID: 20418540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.
    Maue RA; Burgess RW; Wang B; Wooley CM; Seburn KL; Vanier MT; Rogers MA; Chang CC; Chang TY; Harris BT; Graber DJ; Penatti CA; Porter DM; Szwergold BS; Henderson LP; Totenhagen JW; Trouard TP; Borbon IA; Erickson RP
    Hum Mol Genet; 2012 Feb; 21(4):730-50. PubMed ID: 22048958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.
    Cougnoux A; Movassaghi M; Picache JA; Iben JR; Navid F; Salman A; Martin K; Farhat NY; Cluzeau C; Tseng WC; Burkert K; Sojka C; Wassif CA; Cawley NX; Bonnet R; Porter FD
    Dig Dis Sci; 2018 Apr; 63(4):870-880. PubMed ID: 29357083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1.
    Rodriguez-Gil JL; Watkins-Chow DE; Baxter LL; Elliot G; Harper UL; Wincovitch SM; Wedel JC; Incao AA; Huebecker M; Boehm FJ; Garver WS; Porter FD; Broman KW; Platt FM; Pavan WJ
    Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 31996359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of Hepatic Homeostasis in the
    Munkacsi AB; Hammond N; Schneider RT; Senanayake DS; Higaki K; Lagutin K; Bloor SJ; Ory DS; Maue RA; Chen FW; Hernandez-Ono A; Dahlson N; Repa JJ; Ginsberg HN; Ioannou YA; Sturley SL
    J Biol Chem; 2017 Mar; 292(11):4395-4410. PubMed ID: 28031458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC disease.
    Xie C; Gong XM; Luo J; Li BL; Song BL
    J Lipid Res; 2017 Mar; 58(3):512-518. PubMed ID: 28053186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.
    Torres S; Matías N; Baulies A; Nuñez S; Alarcon-Vila C; Martinez L; Nuño N; Fernandez A; Caballeria J; Levade T; Gonzalez-Franquesa A; Garcia-Rovés P; Balboa E; Zanlungo S; Fabrías G; Casas J; Enrich C; Garcia-Ruiz C; Fernández-Checa JC
    Redox Biol; 2017 Apr; 11():60-72. PubMed ID: 27888692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.
    Ramirez CM; Lopez AM; Le LQ; Posey KS; Weinberg AG; Turley SD
    Biochim Biophys Acta; 2014 Jan; 1841(1):54-61. PubMed ID: 24076310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-Pick disease, type C.
    King KA; Gordon-Salant S; Pawlowski KS; Taylor AM; Griffith AJ; Houser A; Kurima K; Wassif CA; Wright CG; Porter FD; Repa JJ; Brewer CC
    J Assoc Res Otolaryngol; 2014 Aug; 15(4):529-41. PubMed ID: 24839095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of gene expression profile in Niemann-Pick type C mice correlates with tissue damage and oxidative stress.
    Vázquez MC; del Pozo T; Robledo FA; Carrasco G; Pavez L; Olivares F; González M; Zanlungo S
    PLoS One; 2011; 6(12):e28777. PubMed ID: 22216111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endo-lysosomal dysfunction and neuronal-glial crosstalk in Niemann-Pick type C disease.
    Malara M; Prestel M; Tahirovic S
    Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220388. PubMed ID: 38368932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1.
    Cluzeau CV; Watkins-Chow DE; Fu R; Borate B; Yanjanin N; Dail MK; Davidson CD; Walkley SU; Ory DS; Wassif CA; Pavan WJ; Porter FD
    Hum Mol Genet; 2012 Aug; 21(16):3632-46. PubMed ID: 22619379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.
    Nicoli ER; Al Eisa N; Cluzeau CV; Wassif CA; Gray J; Burkert KR; Smith DA; Morris L; Cologna SM; Peer CJ; Sissung TM; Uscatu CD; Figg WD; Pavan WJ; Vite CH; Porter FD; Platt FM
    PLoS One; 2016; 11(3):e0152007. PubMed ID: 27019000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.
    Lopez AM; Terpack SJ; Posey KS; Liu B; Ramirez CM; Turley SD
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):780-7. PubMed ID: 25115571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for
    Tseng WC; Loeb HE; Pei W; Tsai-Morris CH; Xu L; Cluzeau CV; Wassif CA; Feldman B; Burgess SM; Pavan WJ; Porter FD
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Npc1 deficiency in the C57BL/6J genetic background enhances Niemann-Pick disease type C spleen pathology.
    Parra J; Klein AD; Castro J; Morales MG; Mosqueira M; Valencia I; Cortés V; Rigotti A; Zanlungo S
    Biochem Biophys Res Commun; 2011 Sep; 413(3):400-6. PubMed ID: 21910975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte-only Npc1 reduces neuronal cholesterol and triples life span of Npc1-/- mice.
    Zhang M; Strnatka D; Donohue C; Hallows JL; Vincent I; Erickson RP
    J Neurosci Res; 2008 Oct; 86(13):2848-56. PubMed ID: 18500759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.
    Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM
    Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.